(E)-1,1,1,2,2,3,3,4,4-nonafluoropentadec-5-ene

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 有机氟化物
• 英文名称: (E)-1,1,1,2,2,3,3,4,4-nonafluoropentadec-5-ene
• 化学式: C₁₅H₂₁F₉
• 分子量: 372.31
• InChiKey: UJBMLXPZRNDSFN-ZHACJKMWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  8.4
• 重原子数：
  24
• 可旋转键数：
  11
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.87
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  9

文献信息

• LUNG SURFACTANT SUPPLEMENTS
  申请人：CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)

  公开号：EP1740189A1

  公开（公告）日：2007-01-10
• Lung Surfactant Supplements
  申请人：Krafft Marie-Pierre

  公开号：US20080019926A1

  公开（公告）日：2008-01-24

  The invention relates to a method for improving the fluidity and/or the spreadability of the native lung surfactant in a human or animal in need of such treatment, wherein the human or animal is administered with a fluorocarbon composition. The invention further relates to therapeutic compositions comprising a fluorocarbon, optionally in combination with a phospholipid, and their use as lung surfactant supplements.
• [EN] LUNG SURFACTANT SUPPLEMENTS<br/>[FR] COMPLEMENTS DE SURFACTANT PULMONAIRE
  申请人：CENTRE NAT RECH SCIENT

  公开号：WO2005099718A1

  公开（公告）日：2005-10-27

  The invention relates to a method for improving the fluidity and/or the spreadability of the native lung surfactant in a human or animal in need of such treatment, wherein the human or animal is administered with a fluorocarbon composition. The invention further relates to therapeutic compositions comprising a fluorocarbon, optionally in combination with a phospholipid, and their use as lung surfactant supplements.